Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-11 Sale | 2022-08-15 4:16 pm | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 20,000 | $36.52 | $730,485 | 45,406 (Direct) | View |
| 2021-12-23 Sale | 2021-12-28 4:02 pm | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 9,500 | $42 | $399,000 | 58,329 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 4:02 pm | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 9,500 | $43.57 | $413,883 | 67,829 (Direct) | View |
| 2021-08-10 Sale | 2021-08-12 10:00 am | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 2,738 | $45.25 | $123,895 | 77,329 (Direct) | View |
| 2020-06-09 Purchase | 2020-06-10 07:55 am | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 9,750 | $3.05 | $29,738 | 10,735 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Exercise | 2024-01-04 4:05 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 10,750 | $2.78 | 35,128 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:05 pm | N/A 2029-06-19 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 10,750 | $0 | 35,128 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:17 pm | 2024-06-15 2033-06-15 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-15 4:16 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 13,671 | $2.78 | 45,406 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 4:16 pm | N/A 2028-06-13 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 20,000 | $0 | 45,406 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 4:16 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 6,329 | $9.0165 | 45,406 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:13 pm | 2023-06-16 2032-06-16 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-12-23 Exercise | 2021-12-28 4:02 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 3,750 | $2.78 | 58,329 (Direct) | View |
| 2021-12-23 Exercise | 2021-12-28 4:02 pm | N/A 2028-06-13 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 7,000 | $0 | 58,329 (Direct) | View |
| 2021-12-23 Exercise | 2021-12-28 4:02 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 3,250 | $9.0165 | 58,329 (Direct) | View |
| 2021-11-15 Exercise | 2021-11-17 4:02 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 3,750 | $2.78 | 67,829 (Direct) | View |
| 2021-11-15 Exercise | 2021-11-17 4:02 pm | N/A 2028-06-13 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 7,000 | $0 | 67,829 (Direct) | View |
| 2021-11-15 Exercise | 2021-11-17 4:02 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 3,250 | $9.0165 | 67,829 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-12 10:00 am | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 11,079 | $2.78 | 77,329 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-12 10:00 am | N/A 2028-06-13 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 21,381 | $0 | 77,329 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-12 10:00 am | N/A N/A | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 10,302 | $9.0165 | 77,329 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:26 pm | 2022-06-17 2031-06-17 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-19 08:07 am | 2021-06-18 2030-06-18 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 105,600 | $0 | 105,600 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-20 4:27 pm | 2020-06-19 2029-06-19 | Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO | 43,000 | $0 | 43,000 (Direct) | View |